AwesomeCapital
Search This Blog
Thursday, September 5, 2019
Orchard Therapeutics started at Overweight by Barclays
Target $21
https://www.benzinga.com/stock/ORTX/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.